Inquiry Basket
Loading ......
Filter By Product Search for
Taurine
Taurine Full Name
Taurine
Taurine Introduction
Taurine is a naturally occurring sulfur-containing amino acid that has attracted growing attention as both a metabolic regulator and a potential therapeutic molecule across multiple disease areas. Although taurine itself is not a classical receptor ligand with a single dominant molecular target, its biological activity depends on a network of transporters, ion channels, and intracellular signaling pathways that collectively maintain cellular homeostasis. Among these, the taurine transporter SLC6A6 (TauT) is recognized as the principal high-affinity, sodium- and chloride-dependent transporter responsible for taurine uptake in the nervous system, retina, heart, skeletal muscle, kidney, and other metabolically active tissues. Recent structural studies have substantially advanced understanding of TauT by resolving its molecular architecture and elucidating the coordinated sodium/chloride binding mechanism that drives taurine transport, providing a framework for structure-guided drug discovery. These findings have positioned SLC6A6 as an emerging pharmacological target not only for improving taurine homeostasis but also for developing selective inhibitors and modulators with potential applications in oncology, retinal disorders, and reproductive medicine. For researchers investigating taurine biology or evaluating novel therapeutic strategies, understanding the SLC6A6-mediated transport mechanism has become increasingly important because intracellular taurine availability largely determines the compound's downstream biological effects.
The functional significance of taurine extends well beyond nutrient transport, as it participates in multiple protective pathways that preserve cellular integrity under physiological and pathological stress. Taurine contributes to mitochondrial function by maintaining electron transport chain efficiency, preserving glutathione pools, limiting excessive reactive oxygen species generation, and reducing oxidative damage to proteins, lipids, and DNA. It also regulates intracellular calcium homeostasis, osmotic balance, membrane stability, protein phosphorylation, and inflammatory signaling, thereby protecting cells against apoptosis and metabolic dysfunction. In the central nervous system, taurine influences neuronal excitability through interactions with inhibitory neurotransmission and calcium-dependent signaling pathways, supporting synaptic stability and neuronal survival. These pleiotropic functions explain why taurine deficiency often produces multisystem abnormalities rather than isolated phenotypes. Current evidence suggests that taurine acts as a homeostatic regulator capable of integrating metabolic, antioxidant, anti-inflammatory, and cytoprotective responses, making it highly relevant for investigators seeking therapeutic approaches that target multiple interconnected disease mechanisms instead of a single signaling pathway.
Increasing clinical and experimental evidence has linked taurine dysregulation and SLC6A6 dysfunction to a broad spectrum of human diseases. Loss-of-function mutations in SLC6A6 can impair taurine uptake, leading to systemic taurine deficiency, early-onset retinal degeneration, progressive photoreceptor loss, blue cone dysfunction, and retinal dystrophy, highlighting the essential role of TauT in maintaining retinal health. Beyond ophthalmology, altered taurine metabolism has been associated with neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and other neurological conditions characterized by oxidative stress, mitochondrial dysfunction, neuroinflammation, and calcium imbalance. In cardiovascular disease, taurine has demonstrated cardioprotective properties through modulation of oxidative injury, calcium handling, and energy metabolism, while emerging studies also implicate aberrant SLC6A6 expression in cancer progression, suggesting that transporter-directed therapies may offer new opportunities in precision oncology. Although many mechanistic and clinical questions remain under investigation, current research consistently supports taurine and its transporter network as promising therapeutic targets whose modulation may benefit neurological, retinal, metabolic, cardiovascular, and oncological diseases, warranting continued translational and clinical development.
Alternate Names for Taurine
Taurine; 2 aminoethanesulfonic acid; 2-sulfoethylamine; 2-Aminoαthylsulfonsαure; TATU; TAURINE,REAGENT; Ethylaminosulfonic acid; O-Due; Aminoethanesulfonic acid; TaurineForSynthesis; TURIN
Loading ......
